
E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & Podcasts
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting to...
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kina...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Apr 30, 2025, 18:13 long, audio available.
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here:
You can listen to E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA online on Radio and Podcast. Open the player on this page to stream the available audio.
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 18:13 long.
This episode was published on Apr 30, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA on this page when the episode audio is available from the podcast feed.
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Apr 30, 2025 and 18:13 long